These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7284267)

  • 21. Anthralin: how does it act and are there more favourable derivatives?
    Mahrle G; Bonnekoh B; Wevers A; Hegemann L
    Acta Derm Venereol Suppl (Stockh); 1994; 186():83-4. PubMed ID: 8073848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.
    Müller K; Leukel P; Ziereis K; Gawlik I
    J Med Chem; 1994 May; 37(11):1660-9. PubMed ID: 8201600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A semiempirical computational investigation of the antipsoriatic drug anthralin.
    Holder AJ; Upadrashta SM
    J Pharm Sci; 1992 Nov; 81(11):1074-8. PubMed ID: 1447707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of anthralin in skin during treatment.
    Juhlin L; Schroot B
    Acta Derm Venereol Suppl (Stockh); 1985; 120():27-9. PubMed ID: 3869415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsoriatic therapy and skin cancer.
    Briffa DV
    Br J Dermatol; 1981 Aug; 105 Suppl 20():70. PubMed ID: 7284271
    [No Abstract]   [Full Text] [Related]  

  • 26. Anthralin: historical and current perspectives.
    Ashton RE; Andre P; Lowe NJ; Whitefield M
    J Am Acad Dermatol; 1983 Aug; 9(2):173-92. PubMed ID: 6309924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An EPR study of free radicals formed by antipsoriatic and tumor-promoting 9-anthrones in nonpolar solvents.
    Motten AG; Sik RH; Chignell CF; Hayden PJ
    Chem Res Toxicol; 1994; 7(6):877-81. PubMed ID: 7696546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-function relationship of new anthralin derivatives assayed for growth inhibition and cytotoxicity in human keratinocyte cultures.
    Bonnekoh B; Tanzer H; Seidel M; Geisel J; Merk HF; Mahrle G; Wiegrebe W
    Arch Pharm (Weinheim); 1991 Nov; 324(11):899-906. PubMed ID: 1804068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status and recent developments in anthracenone antipsoriatics.
    Müller K
    Curr Pharm Des; 2000 Jun; 6(9):901-18. PubMed ID: 10828315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Psoradrate (dithranol) cream].
    Nyfors A
    Ugeskr Laeger; 1983 Mar; 145(13):1006-7. PubMed ID: 6857800
    [No Abstract]   [Full Text] [Related]  

  • 31. Anthralin therapy for psoriasis. A new look at an old compound.
    Gorsulowsky DC; Voorhees JJ; Ellis CN
    Arch Dermatol; 1985 Dec; 121(12):1509-11. PubMed ID: 4062331
    [No Abstract]   [Full Text] [Related]  

  • 32. Anthralin cream as short contact therapy for psoriasis.
    Miller AC
    Cutis; 1985 Jun; 35(6):578-82. PubMed ID: 4017653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current concepts in the mode of action of anthralin in the treatment of psoriasis.
    Br J Dermatol; 1981 Aug; 105 Suppl 20():1-114. PubMed ID: 7284252
    [No Abstract]   [Full Text] [Related]  

  • 34. A 'novel' action of anthralin.
    Lotti T; Brunetti L; Panconesi E
    Arch Dermatol; 1986 Jul; 122(7):748-9. PubMed ID: 3729504
    [No Abstract]   [Full Text] [Related]  

  • 35. [A very promising treatment method in psoriasis. Short-term anthralin therapy].
    Kunze J; Petres J
    Fortschr Med; 1981 May; 99(20):761-4. PubMed ID: 7262756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the use of anthralin.
    Seville RH
    J Am Acad Dermatol; 1981 Sep; 5(3):319-21. PubMed ID: 7263977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsoriatic drug action of anthralin: oxidation reactions with peroxidizing lipids.
    Ducret F; Lambelet P; Löliger J; Savoy MC
    J Free Radic Biol Med; 1985; 1(4):301-6. PubMed ID: 3836247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anthralin therapy for psoriasis.
    Statham BN; Ryatt KS; Rowell NR
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):303-4. PubMed ID: 6480932
    [No Abstract]   [Full Text] [Related]  

  • 39. [Suppression of cignolin-induced erythema by tar].
    Schulze HJ
    Z Hautkr; 1984 May; 59(10):659-62. PubMed ID: 6741205
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of psoriasis vulgaris: gentleness to the entire psoriatic skin and the use of low concentrations of anthralin.
    Brody I
    Br J Dermatol; 1981 Aug; 105 Suppl 20():109-10. PubMed ID: 7284255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.